Cardio Diagnostics Holdings, Inc. (CDIO)
1.925
-0.10
(-5.17%)
USD |
NASDAQ |
Aug 24, 16:00
1.97
+0.04
(+2.34%)
After-Hours: 20:00
Cardio Diagnostics Holdings Profit Margin (Quarterly) : -27.81K% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -27.81K% |
| March 31, 2026 | -66.23K% |
| December 31, 2025 | -40.71K% |
| September 30, 2025 | -59.12K% |
| June 30, 2025 | -22.44K% |
| March 31, 2025 | -181.7K% |
| December 31, 2024 | -33.76K% |
| Date | Value |
|---|---|
| September 30, 2024 | -21.40K% |
| June 30, 2024 | -16.30K% |
| March 31, 2024 | -26.19K% |
| December 31, 2023 | -26.21K% |
| September 30, 2023 | -19.32K% |
| June 30, 2023 | -236.6K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Tenax Therapeutics, Inc. | -- |
| Exicure, Inc. | -- |
| Century Therapeutics, Inc. | -- |
| Absci Corp. | -10.44K% |
| Celularity, Inc. | -593.6% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -78.55% |
| Return on Assets | -63.18% |
| Return on Invested Capital | -73.71% |
| Gross Profit Margin (Quarterly) | -824.1% |
| Operating Margin (Quarterly) | -27.74K% |
| Return on Net Operating Assets | -361.1% |